SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY SCORE (SLE- DAS) VALIDATION IN ARGENTINIAN PATIENTS

被引：0

作者：

Pera, M. ^{[1
]}

Barbaglia, A. L. ^{[1
]}

Sueldo, H. R. ^{[1
]}

Gonzalez Lucero, L. ^{[1
]}

Corbalan, P. M. ^{[1
]}

Bertolaccini, M. C. ^{[1
]}

Espasa, G. V. ^{[1
]}

Leguizamon, M. L. ^{[1
]}

Galindo, L. M. ^{[1
]}

Ornella, S. ^{[2
]}

Garcia, L. ^{[2
]}

Scafati, J. ^{[2
]}

Cosentino, M. ^{[2
]}

Papasidero, S. ^{[3
]}

Dapena, J. M. ^{[3
]}

Medina, M. A. ^{[3
]}

Scolnik, M. ^{[4
]}

Fernandez-Avila, D. ^{[4
]}

Pisoni, C. ^{[5
]}

Cosatti, M. ^{[5
]}

Rebak, J. ^{[6
]}

Sorrentino, L. ^{[6
]}

Magri, S. J. ^{[7
]}

Gobbi, C. ^{[8
]}

Matellan, C. E. ^{[9
]}

Bellomio, V. I.

机构：

[1] Hosp Angel C Padilla, San Miguel De Tucuman, Tucuman, Argentina

[2] HIGA San Martin, La Plata, Buenos Aires, Argentina

[3] Hosp Gen Agudos Dr Enrique Tornu, Buenos Aires, DF, Argentina

[4] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina

[5] CEMIC, Buenos Aires, DF, Argentina

[6] Sanatorio Guemes Hosp Privado, Buenos Aires, DF, Argentina

[7] Hosp Italiano, La Plata, Buenos Aires, Argentina

[8] Univ Nacl Cordoba, Hosp Cordoba, Fac Ciencias Med, Cordoba, Argentina

[9] Ctr Especialidades Med, Rio Grande, Tierra Fuego, Argentina

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.2823

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0511

引用

页码：1383 / 1383

页数：1

共 50 条

[31] Influence of overweight on the disease progression of patients with systemic Lupus erythematosus (SLE)
Beer, S.
Winkler-Rohlfing, B.
Richter, J.
Willers, R.
Schneider, M.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 69 - 69
[32] DETECTION OF CHANGES IN SLE DISEASE ACTIVITY IS HIGHLY IMPROVED WITH SLE-DAS AS COMPARED TO SLEDAI: DERIVATION AND PRELIMINARY VALIDATION OF THE SLE DISEASE ACTIVITY SCORE (SLE-DAS)
Jesus, D.
Matos, A.
Henriques, C.
Zen, M.
Doria, A.
Jap, D. S.
Ines, L.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 842 - 843
[33] Effect of SLE-DAS Remission on Quality of Life in Patients with Systemic Lupus Erythematosus: A Cross-sectional Validation Study
Lam, Fung
To, Chi Hung
Mok, Chi Chiu
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4592 - 4593
[34] Disease activity, cumulative damage and quality of life in systemic lupus erythematosus (SLE).
Hanly, JG
ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 264 - 264
[35] IGG SUBCLASS LEVELS AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
MAYUS, J
KAINE, J
NAHM, M
FEDERATION PROCEEDINGS, 1985, 44 (05) : 1716 - 1716
[36] Validation of disease activity self-assessment tool in systemic lupus erythematosus patients
Sushchuk, EA
Stepanova, NN
Brenes-Kesada, EG
Chashchina, AV
Zborovskaya, IA
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 234 - 234
[37] Systemic Lupus Erythematosus, a Pilot Study of a New Disease Activity Score
Paran, Daphna
Ben-Am, Monique
Mendel, Liran
Polachek, Ari
Furer, Victoria
Elalouf, Ofi R.
Wollman, Jonathan
Kivity, Shaye
Agmon-Levin, Nancy
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1787 - 1788
[38] Patients' perception of systemic lupus erythematosus disease activity
Sushchuk, EA
Torgashina, AV
RHEUMATOLOGY, 2005, 44 : I137 - I137
[39] PERFORMANCE OF THE NEW ACR/EULAR 2019 CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN A COHORT OF ARGENTINIAN PATIENTS
Dapena, J. M.
Serrano, E. R.
Bande, J. M.
Medina, M. A.
Klajn, D. S.
Caracciolo, J. A.
Castro, C.
Morbiducci, J.
Merce, A. L.
Tralice, R.
Espasa, G. V.
Yessika Jackeline, S.
Leguizamon, M. L.
Pera, M. A.
Bellomio, V. I.
Yacuzzi, M. S.
Machado Escobar, M.
Cosentino, M.
Garcia, L.
Garcia, M.
Aeschlimann, C.
Gomez, G.
Perez, N.
Papasidero, S.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 635 - 635
[40] DOES HIGH DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS INCREASE THE RISK OF CANCER INCIDENCE?
Abdalla, A. M.
Abdelrahman, F. I.
OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S445 - S446

← 1 2 3 4 5 →